Kathryn E. Falberg - Nov 30, 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Director
Signature
Kathryn E. Falberg, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Nov 30, 2022
Transactions value $
$483,836
Form type
4
Date filed
12/5/2022, 04:10 PM
Previous filing
Jun 16, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Purchase $139K +75K $1.85 75K Nov 30, 2022 By Trust F1, F2
transaction NUVB Class A Common Stock Purchase $168K +85K +113.22% $1.97 160K Dec 1, 2022 By Trust F2, F3
transaction NUVB Class A Common Stock Purchase $93.2K +47K +29.38% $1.98 207K Dec 2, 2022 By Trust F2, F4
transaction NUVB Class A Common Stock Purchase $84K +43K +20.77% $1.95 250K Dec 5, 2022 By Trust F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.805 to $1.90. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2 Shares are held directly by The Falberg-Predovich Family Trust, of which the Reporting Person is Co-Trustee.
F3 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.92 to $1.99. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F4 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.925 to $2.00. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.